New Hampshire HB 513: relative to affordability and safety of clinician administered drugs.

Status: Committee Report: Refer for Interim Study 11/08/2023 (Vote 19-0; CC) (as of 2023-11-16)

State: New Hampshire · Session: 2023 · Bill: HB 513

Sponsors: Tim S McGough

View New Hampshire HB 513 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.